255
Participants
Start Date
April 28, 2022
Primary Completion Date
September 30, 2022
Study Completion Date
October 24, 2022
Fisher Wallace Cranial Electrotherapy Stimulator (Active Device)
The indicated use in adults (ages 21-65 years) is for 20 minutes twice daily, upon waking for the day and at bedtime. The treatment period of the intervention will have a duration of four weeks.
Fisher Wallace Cranial Electrotherapy Stimulator (Placebo Device)
The placebo device is designed to provide exactly the same patient experience as the active device; however, the placebo device will not deliver the same frequencies as the active device. The placebo device will provide no therapeutic benefit.
New York Neuromodulation Medical, PLLC, New York
Lead Sponsor
Collaborators (2)
NAMSA
OTHER
Climb Technologies, Inc.
INDUSTRY
Fisher Wallace Laboratories
INDUSTRY